Wall Street predicts approval for another ALS drug By: MarketWatch March 21, 2023 at 10:45 AM EDT An FDA advisory committee is set to meet this week to discuss a drug developed by Biogen and Ionis to treat a rare form of Lou Gehrig's disease. Read More >> Related Stocks: Amylyx Pharmaceuticals, Inc. - Common Stock Biogen Idec Ionis Pharmaceuticals
